Aurinia Pharmaceuticals (AUPH) has released an update.
Aurinia Pharmaceuticals Inc., a Canadian company, has filed a current report on Form 8-K with the U.S. Securities and Exchange Commission to comply with Sections 13 or 15(d) of the Securities Exchange Act of 1934, as of August 1, 2024. The report reveals the company’s common shares are registered and traded on The Nasdaq Stock Market under the symbol AUPH.
For further insights into AUPH stock, check out TipRanks’ Stock Analysis page.
